EU research projects

IDF Europe welcomes the opportunity to take an active role in EU-funded research and other initiatives that aim at improving the health of European citizens, as these contribute to finding new treatments for diabetes and improving the lives of people living with this condition.

Developed within the EU Seventh Framework Programme (FP7) and Horizon 2020 research and innovation programme, these projects encourage the development and validation of new therapies, methods for health promotion and prevention, as well as sustainable and efficient healthcare systems. IDF Europe is currently involved in the following projects: EuRhythdia, ePredice and Feel4diabetes. Past projects in which IDF Europe involved in were EConda, EUROCONDOR, Manage Care, JA-CHRODIS

  • EURHYTHDIA - LIFESTYLE AND DIABETES

    Evidence has accumulated that disruption of our body’s internal clock (the so-called circadian clock) might contribute to the development of Type 2 diabetes and other cardiometabolic complications.

    Few studies have investigated the link between the disruption of the daily sleep-wake pattern and Type 2 diabetes in man. For this reason, a multi-disciplinary consortium of leading academic experts and research-intensive SME’s have joined forces under EuRhythDia, the Consortium on chronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working population. This 5-year project will look at whether lifestyle change to reset the internal clock can significantly reduce the risk of developing Type 2 diabetes and cardiometabolic complications. 

    Principal investigator: Prof Rainer Böger

    Past event(s):

    24 May 2017- Workshop at the German Diabetes Congress, Hamburg, Germany 

    June 2017 - International Taskforce for Prevention of Cardiometabolic Diseases, Aachen, Germany 

    Poster (English)

    Press Release (English)

    Press Release (French)

    Press Release (German)

    Press Release (Italian)

    Press Release (Polish)

    Press Release (Spanish)

     

  • FEEL4DIABETES

    Feel4diabetes (Families across Europe following a healthy lifestyle 4 diabetes prevention) is a EU-funded project aiming to develop, implement and evaluate an evidence-based and potentially cost-effective and scalable intervention programme to prevent type 2 diabetes across Europe, primarily focusing on families from vulnerable groups. The project spans the period 2014 to 2019 and is carried out by a multidisciplinary team of 10 partners across the EU.

    The project focuses on families because risk factors associated with type 2 diabetes tend to cluster within a family given that its members share common genetic background, lifestyle habits, social and physical environment. Promoting healthy behaviours and supportive environmental changes when the family is approached as a whole seems to be more effective compared to targeting the family members individually.

    Feel4Diabetes is implemented in two high-income countries (Belgium and Finland), two countries under economic crisis (Greece and Spain) and two low/middle-income countries (Bulgaria and Hungary).

    IDF Europe’s role in the project is to facilitate events and workshops for the advisory board and partners and to disseminate activities and results with the aim of embedding the learnings derived from the project into policies and practices at the local, national and international level.

    Principal investigator: Assoc Prof Dr Yannis Manios

    Dissemination materals:

    F4D featured in EU Press Release

    One-pager of project update 

    Upcoming event(s):

    7-8 Sep 2017 - Consortium Meeting, Brussels, Belgium

    May 2018 - Dissemination Meeting, Brussels, Belgium

    Spring 2019 - Dissemination Meeting, location tbc

     

  • EPREDICE - EARLY PREVENTION

    ePredice, the Consortium for the Early Prevention of Diabetes Complications in Europe, unites 32 European academics, public healthcare professionals and SMEs with the aim to assess the effects of various medical treatments and lifestyle interventions on different microvascular complications affecting people with intermediate hyperglycaemia and screen-detected Type 2 diabetes.

    This research project comes at a time where new treatments for the early prevention of diabetes complications are increasingly needed. Type 2 diabetes and Impaired Glucose Tolerance (IGT) are the major cause for morbidity and mortality due to associated complications in Europe. 

    The economic burden is steadily rising and, with poor quality of life for people with diabetes due to chronic treatment and multiple complications, early prevention could substantially reduce the socio-economic burden of diabetes in Europe. For more information, please visit www.epredice.eu

    Co-Principal investigators: Prof Jaakko Tuomilehto and Prof Rafael Gabriel

    Upcoming event(s):

    10 Sep 2017 - General Assembly for Consortium Partners, Lisbon, Portugal 

© 2017 International Diabetes Federation Disclaimer